Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Oct 2018

At a glance

  • Drugs Brincidofovir (Primary)
  • Indications Adenovirus infections; Cytomegalovirus infections; Monkeypox; Smallpox; Viral infections
  • Focus Adverse reactions
  • Sponsors Chimerix
  • Most Recent Events

    • 07 Oct 2018 Results presented at the IDWeek 2018
    • 05 Oct 2018 According to a Chimerix media release, data from this study will be presented at IDWeek 2018.
    • 05 Jan 2018 According to a Chimerix media release, the company expects to provide data in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top